Robert D. Hardie - Net Worth and Insider Trading

Robert D. Hardie Net Worth

The estimated net worth of Robert D. Hardie is at least $22 Million dollars as of 2024-06-08. Robert D. Hardie is the 10% Owner of Acumen Pharmaceuticals Inc and owns about 8,277,142 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $22 Million. Details can be seen in Robert D. Hardie's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert D. Hardie has not made any transactions after 2021-07-06 and currently still holds the listed stock(s).

Transaction Summary of Robert D. Hardie

To

Robert D. Hardie Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert D. Hardie owns 2 companies in total, including PLx Pharma Winddown Corp (PLXPQ) , and Acumen Pharmaceuticals Inc (ABOS) .

Click here to see the complete history of Robert D. Hardie’s form 4 insider trades.

Insider Ownership Summary of Robert D. Hardie

Ticker Comapny Transaction Date Type of Owner
PLXPQ PLx Pharma Winddown Corp 2020-11-18 10 percent owner
ABOS Acumen Pharmaceuticals Inc 2021-07-06 10 percent owner

Robert D. Hardie Latest Holdings Summary

Robert D. Hardie currently owns a total of 1 stock. Robert D. Hardie owns 8,277,142 shares of Acumen Pharmaceuticals Inc (ABOS) as of July 6, 2021, with a value of $22 Million.

Latest Holdings of Robert D. Hardie

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABOS Acumen Pharmaceuticals Inc 2021-07-06 8,277,142 2.62 21,686,112

Holding Weightings of Robert D. Hardie


Robert D. Hardie Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert D. Hardie has made a total of 2 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the acquisition of 750,000 shares on July 6, 2021, which cost Robert D. Hardie around $12 Million.

Insider Trading History of Robert D. Hardie

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert D. Hardie Trading Performance

GuruFocus tracks the stock performance after each of Robert D. Hardie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert D. Hardie is -26.49%. GuruFocus also compares Robert D. Hardie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert D. Hardie within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert D. Hardie's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert D. Hardie

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -25.69 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -27.83 LIMIT LIMIT LIMIT LIMIT LIMIT

Robert D. Hardie Ownership Network

Ownership Network List of Robert D. Hardie

No Data

Ownership Network Relation of Robert D. Hardie

Insider Network Chart

Robert D. Hardie Owned Company Details

What does PLx Pharma Winddown Corp do?

Who are the key executives at PLx Pharma Winddown Corp?

Robert D. Hardie is the 10 percent owner of PLx Pharma Winddown Corp. Other key executives at PLx Pharma Winddown Corp include director & Chief Executive Officer Natasha Giordano , Chief Financial Officer Rita M O'connor , and director & Executive Chairman Michael J Valentino .

PLx Pharma Winddown Corp (PLXPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PLx Pharma Winddown Corp (PLXPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PLx Pharma Winddown Corp (PLXPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PLx Pharma Winddown Corp (PLXPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PLx Pharma Winddown Corp Insider Transactions

No Available Data

Robert D. Hardie Mailing Address

Above is the net worth, insider trading, and ownership report for Robert D. Hardie. You might contact Robert D. Hardie via mailing address: 210 Ridge Mcintire Road, Suite 350, Charlottesville Va 22903.

Discussions on Robert D. Hardie

No discussions yet.